To investigate the effects of antihypertensive treatment with four currently used agents (trichlormethiazide, atenolol, nicardipine, and enalapril) on the arterial baroreceptor function at the early phase of hypertension, we administered the agents to spontaneously hypertensive rats and WistarKyoto rats from 8 to 10 weeks of age and examined the aortic nerve activity function. In untreated spontaneously hypertensive rats, the relation between the arterial pressure and aortic nerve activity was shifted to the right, that is, to a higher pressure level (threshold pressure, 90±3 versus 76±1 mm Hg, P<.05), and the maximum gain which was obtained by logistic function analysis was depressed (1.55±0.08% versus 2.18±0.13% maximum/mm Hg, f<.01) as compared with untreated Wistar-Kyoto rats. An equivalent decrease in arterial pressure with each of the four agents (-20±l mm Hg, P<.01) B aroreceptor activity transmitted to the central nervous system (CNS) is a primary signal concerning moment-to-moment alterations in arterial pressure and represents a fundamental mechanism in the neural control of the circulation because it triggers reflex inhibition of sympathetic nerve activity and excitation of parasympathetic nerve activity that buffers the rise in pressure. It is known that the baroreceptor function is depressed in several forms of hypertension. 1 " 3 Impaired baroreceptor input to the CNS elicits instability of the circulation, 4 which tends in turn to lead to increases in cardiovascular morbidity and mortality. Agents that effectively potentiate the baroreceptor function are considered preferable in the treatment of hypertension. Early studies have shown that conventional antihypertensive therapy with combinations of drugs (diuretics, vasodilators, and adrenergic antagonists) increased the baroreceptor sensitivity in spontaneously hypertensive rats (SHRs). classes of antihypertensive agents might exert distinct effects on the baroreceptor function through specific pharmacological actions when administered chronically to hypertensive subjects. To test this hypothesis, we treated SHRs with one of four currently used agents (a diuretic, a j3-adrenergic blocker, a calcium channel blocker, and an ACE inhibitor) for 2 weeks and examined the effects on the aortic baroreceptor function. Moreover, we used relatively young SHRs (10 weeks of age) in which the characteristics of the aorta are less damaged by hypertension 3